首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   266篇
  免费   7篇
  国内免费   24篇
耳鼻咽喉   5篇
儿科学   2篇
妇产科学   2篇
基础医学   47篇
口腔科学   1篇
临床医学   40篇
内科学   25篇
皮肤病学   3篇
神经病学   26篇
特种医学   14篇
外科学   59篇
综合类   10篇
预防医学   23篇
眼科学   9篇
药学   25篇
肿瘤学   6篇
  2021年   4篇
  2020年   2篇
  2019年   2篇
  2018年   5篇
  2017年   2篇
  2016年   6篇
  2015年   11篇
  2014年   9篇
  2013年   16篇
  2012年   18篇
  2011年   20篇
  2010年   11篇
  2009年   8篇
  2008年   13篇
  2007年   24篇
  2006年   11篇
  2005年   9篇
  2004年   8篇
  2003年   8篇
  2002年   10篇
  2001年   3篇
  2000年   8篇
  1999年   3篇
  1998年   4篇
  1997年   4篇
  1996年   5篇
  1995年   2篇
  1994年   2篇
  1993年   4篇
  1992年   7篇
  1991年   3篇
  1990年   5篇
  1989年   6篇
  1988年   6篇
  1987年   2篇
  1986年   2篇
  1985年   3篇
  1984年   2篇
  1983年   3篇
  1979年   3篇
  1977年   2篇
  1975年   2篇
  1972年   2篇
  1971年   4篇
  1970年   2篇
  1964年   1篇
  1938年   1篇
  1934年   1篇
  1927年   1篇
  1894年   1篇
排序方式: 共有297条查询结果,搜索用时 15 毫秒
101.
102.
103.
呼吸衰竭作为临床常见的综合征,由其导致的低氧血症和(或)高碳酸血症严重危及患者的健康甚至生命。现代机械通气技术(主要是正压机械通气技术)作为临床救治呼吸衰竭的最主要手段,使重症呼吸衰竭的病死率从上世纪70年代的90%以上降至目前的40%左右,挽救了众多患者的生命,  相似文献   
104.

Background  

Gender and stability of fixation independently influence bone regeneration but their combined effects are unclear.  相似文献   
105.
106.
107.

Background

Hec1 (NDC80) is an integral part of the kinetochore and is overexpressed in a variety of human cancers, making it an attractive molecular target for the design of novel anticancer therapeutics. A highly potent first-in-class compound targeting Hec1, TAI-1, was identified and is characterized in this study to determine its potential as an anticancer agent for clinical utility.

Methods

The in vitro potency, cancer cell specificity, synergy activity, and markers for response of TAI-1 were evaluated with cell lines. Mechanism of action was confirmed with western blotting and immunofluorescent staining. The in vivo potency of TAI-1 was evaluated in three xenograft models in mice. Preliminary toxicity was evaluated in mice. Specificity to the target was tested with a kinase panel. Cardiac safety was evaluated with hERG assay. Clinical correlation was performed with human gene database.

Results

TAI-1 showed strong potency across a broad spectrum of tumor cells. TAI-1 disrupted Hec1-Nek2 protein interaction, led to Nek2 degradation, induced significant chromosomal misalignment in metaphase, and induced apoptotic cell death. TAI-1 was effective orally in in vivo animal models of triple negative breast cancer, colon cancer and liver cancer. Preliminary toxicity shows no effect on the body weights, organ weights, and blood indices at efficacious doses. TAI-1 shows high specificity to cancer cells and to target and had no effect on the cardiac channel hERG. TAI-1 is synergistic with doxorubicin, topotecan and paclitaxel in leukemia, breast and liver cancer cells. Sensitivity to TAI-1 was associated with the status of RB and P53 gene. Knockdown of RB and P53 in cancer cells increased sensitivity to TAI-1. Hec1-overexpressing molecular subtypes of human lung cancer were identified.

Conclusions

The excellent potency, safety and synergistic profiles of this potent first-in-class Hec1-targeted small molecule TAI-1 show its potential for clinically utility in anti-cancer treatment regimens.  相似文献   
108.
Bone is one of the few tissues in the human body with high endogenous healing capacity. However, failure of the healing process presents a significant clinical challenge; it is a tremendous burden for the individual and has related health and economic consequences. To overcome such healing deficits, various concepts for a local drug delivery to bone have been developed during the last decades. However, in many cases these concepts do not meet the specific requirements of either surgeons who must use these strategies or individual patients who might benefit from them. We describe currently available methods for local drug delivery and their limitations in therapy. Various solutions for drug delivery to bone focusing on clinical applications and intra-operative constraints are discussed and drug delivery by implant coating is highlighted. Finally, a new set of design and performance requirements for intra-operatively customized implant coatings for controlled drug delivery is proposed. In the future, these requirements may improve approaches for local and intra-operative treatment of patients.  相似文献   
109.
The synthesis of block copolymers consisting of nonfunctional and reactive blocks is reported. The precursor polymers are ABA triblock copolymers, consisting of S/VBC or MMA/GMA and prepared via RAFT polymerization. The reactive blocks are converted into blocks with new functionalities that are hard to achieve by direct polymerization. The new polymers are either amphiphilic, with acidic or basic blocks on the outside and a nonfunctional core, or have functionalities that are useful for further reactions like thiol‐ene or alkyne‐azide click reactions. Reaction success and degree of functionalization are determined via FTIR, elemental analysis, and MALDI‐TOF MS. The stability of the RAFT functionalities during the modification reactions is analyzed.  相似文献   
110.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号